{"id":65393,"date":"2020-11-22T23:30:00","date_gmt":"2020-11-23T08:30:00","guid":{"rendered":"https:\/\/www.juneauempire.com\/news\/state-health-officials-vaccine-could-arrive-next-month\/"},"modified":"2020-11-22T23:30:00","modified_gmt":"2020-11-23T08:30:00","slug":"state-health-officials-vaccine-could-arrive-next-month","status":"publish","type":"post","link":"https:\/\/www.juneauempire.com\/news\/state-health-officials-vaccine-could-arrive-next-month\/","title":{"rendered":"State health officials: Vaccine could arrive next month"},"content":{"rendered":"\n\t\t\t\t
A COVID-19 vaccine is expected to arrive in Alaska early next month and could begin distribution to prioritized populations as soon as Dec. 22, said Alaska’s chief medical officer Dr. Anne Zink in a Monday news conference. Though the environment around vaccine distribution was “highly variable and rapidly changing,” Zink said that was the most recent date given by Operation Warp Speed, the federal governments’ COVID-19 vaccine program.<\/p>\n\t\t\t\t
Speaking to reporters alongside other members of the Alaska COVID-19 Vaccine Task Force, Zink said state, local and tribal authorities worked together to draft a prioritization list and schedule for vaccine distribution for months, but the exact details of those plans depend on a lot of different information, some of which is not yet available.<\/p>\n\t\t\t\t
Pfizer, one of the world’s largest pharmaceutical companies, submitted a request for an Emergency Use Authorization on Friday, said Tess Walker Linderman from the Alaska Department of Health and Social Services, which was the beginning of the current vaccine timeline. The Federal Drug Administration scheduled a meeting for Dec. 10, to approve the EUA, she said, and once that happens vaccines would then be quickly sent to states.<\/p>\n\t\t\t\t
States will then need to decide which populations get the vaccine first, with vulnerable populations and health care workers likely being among the first. How the state makes that decision will depend on several different things. There are a handful of different vaccines being produced, said state epidemiologist Dr. Joe McLaughlin, and those vaccines affect populations differently. One of the issues for the state is that without that information it’s difficult to know how best to use a certain vaccine.<\/p>\n\t\t\t\t
“As the science continues to progress we might see differential effects,” McLaughlin said. “That’s all information that is forthcoming, but that will also weigh into our decision-making process.”<\/p>\n\t\t\t\t
The federal Centers for Disease Control and Prevention has a vaccine advisory committee that will issue recommendations on how best to use Pfizer’s vaccine following the anticipated approval of the EUA in December, at which point the state would issue its own refined recommendations. Zink described the layers of recommendations like nesting-dolls, where the state’s recommendations would be based on federal ones, and local guidelines based on the state’s recommendations.<\/p>\n\t\t\t\t
Zink said local authorities will have a fair amount a control over their own distribution plans as local health agencies will need flexibility in how they distribute the vaccine.<\/p>\n\t\t\t\t